Genmab — December 2017
-
Frustrerende, men casen ser dog stadigvæk solid ud. Blot træls at skulle helt ned hvor vi er nu.
-
Jeg bliver simpelthen nødt til at sige, at uanset om Genmab måtte have givet anledning til en misforståelse om guiding, finder jeg det dybt uprofessionelt og helt uden for al rimelighed, hvis analytikerne i dag med deres mangelfulde rådgivning har bidraget til at deres kunder har solgt ud.
-
Kommer der slagstal på næste tirsdag/onsdag?
-
*salgstal
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind